- Ad-hoc-news.de2026. 07. 03. 16:00
Kezar Life Sciences updates its autoimmune pipeline as investors assess long-term prospects - Ad-hoc-news.de
Kezar Life Sciences updates its autoimmune pipeline as investors assess long-term prospects Ad-hoc-news.de
- dars.gov.et2026. 06. 16. 16:00
Kezar Life Sciences (KZR) Consolidates at $7.29 as Traders Eye Key Support and Resistance Levels - Continuation Pattern Picks - dars.gov.et
Kezar Life Sciences (KZR) Consolidates at $7.29 as Traders Eye Key Support and Resistance Levels - Continuation Pattern Picks dars.gov.et
- dars.gov.et2026. 05. 29. 16:00
Kezar Life Sciences Q1 2026 Earnings: EPS Misses Estimates as Clinical-Stage Biotech Reports No Revenue - dars.gov.et
Kezar Life Sciences Q1 2026 Earnings: EPS Misses Estimates as Clinical-Stage Biotech Reports No Revenue dars.gov.et
- dars.gov.et2026. 05. 29. 16:00
Kezar Life Sciences (KZR) Holds Steady at $7.29 – Key Levels in Focus - Hull Moving Average - dars.gov.et
Kezar Life Sciences (KZR) Holds Steady at $7.29 – Key Levels in Focus - Hull Moving Average dars.gov.et
- TMX Newsfile2026. 05. 19. 21:30
Aurinia Pharmaceuticals Completes Successful Tender Offer for Kezar Life Sciences
- TMX Newsfile2026. 05. 19. 16:00
Aurinia Pharmaceuticals Completes Successful Tender Offer for Kezar Life Sciences - TMX Newsfile
Aurinia Pharmaceuticals Completes Successful Tender Offer for Kezar Life Sciences TMX Newsfile
